- Home
- RANI vs RDZN Comparison
RANI vs RDZN Comparison
Compare RANI & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RANI | RDZN |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | 459 |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9M | 104.8M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RANI | RDZN |
|---|---|---|
| Price | $0.77 | $1.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 484.3K | 319.4K |
| Earning Date | 05-07-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.14 | ★ 72.12 |
| EPS | ★ N/A | N/A |
| Revenue | $1,633,000.00 | ★ $55,021,792.00 |
| Revenue This Year | $274.77 | $33.77 |
| Revenue Next Year | $79.44 | $51.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 58.85 | 24.21 |
| 52 Week Low | $0.45 | $0.81 |
| 52 Week High | $3.87 | $2.56 |
Technical Indicators
Market Signals| Indicator | RANI | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 45.48 |
| Support Level | $0.73 | $1.05 |
| Resistance Level | $0.83 | $1.30 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.77 | 55.67 |
Price Performance
Historical ComparisonAbout RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express. Geographically, the company operates in India, United States of America, United Kingdom, and China. It generates maximum revenue form India.